|
Cerestar will be exhibiting its range of high quality starches and starch derivatives for the pharmaceutical industry at CPhI UK 2001, in London on 8-10 October.
In addition to the Cerestar exhibits, Mrs. Elsie van Bogaert, from Cerestar's Application Centre Pharma & Chemical in Vilvoorde, Belgium, will present a lecture titled 'Erythritol – a new functional excipient' during the CPhI 2001 exhibition.
Cerestar offers a complete range of starch derived products for pharmaceutical applications. The company's comprehensive range includes starch and pregelatinised starch, maltodextrins, glucose and liquid glucose, and a wide range of polyols, isosorbide and cyclodextrins.
Meeting the highest quality standards required by the pharmaceutical industry, Cerestar's products are designed for applications such as enteral and parental nutrition, excipients for tabletting and liquid formulations, pill coatings and slow release formulations. The company's range of pyrogen-free injectable qualities includes glucose monohydrate, mannitol, xylitol and sorbitol.
By offering consistently high quality products, a state-of-the-art technical service and efficient delivery, Cerestar is committed to building enduring partnerships with its customers in the pharmaceutical industry.
Cerestar is a global manufacturer of starch and its derivatives. As market leader in Europe and the fifth largest starch producer in the USA, Cerestar's headquarters are in Paris, while its sales offices and 17 production facilities are located throughout the world. Cerestar's Application Centre Pharma & Chemical in Vilvoorde, Belgium, is equipped with state-of-the-art technology housed in several on-site laboratories.
Find out more by visiting stand S10 in the North Hall at CPhI (London) 2001 or contact Cerestar Headquarters on +33 (0)141 43 19 24/25.
|
